NCT06284447

Brief Summary

This study evaluates barriers to cervical cancer screening among non-compliant women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,216

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

February 22, 2024

Last Update Submit

May 16, 2025

Conditions

Cervical Carcinoma

Outcome Measures

Primary Outcomes (1)

  • Identify barriers to cervical cancer screening

    Participants will receive a brief "Pap Smear Barriers Survey" (likely completed in 5-15 minutes) which asks yes/no/no preference questions regarding potential barriers to cervical cancer screening. Responses will be compared regionally and by Mayo Clinic Health System site.

    Baseline

Study Arms (1)

Observational

Participants complete a survey on study.

Other: Non-Interventional Study

Interventions

Non-Interventional StudyOTHER

Non interventional study

Observational

Eligibility Criteria

Age21 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women aged 21-65 that are non-compliant for cervical cancer screening within the Mayo Clinic Health System

You may qualify if:

  • Women between the ages of 21-65
  • Non-compliant for cervical cancer screening within Mayo Clinic Primary Care

You may not qualify if:

  • Women less than 21 or older than 65
  • Complaint for cervical cancer screening within Mayo Clinic Primary Care
  • Women who decline participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Brittany A. Strelow, DSMc, PA-C

    Mayo Clinic in Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2024

First Posted

February 29, 2024

Study Start

March 23, 2023

Primary Completion

October 28, 2023

Study Completion

October 28, 2023

Last Updated

May 21, 2025

Record last verified: 2025-05

Locations

US(1)